chlordiazepoxide hydrochloride and clidinium bromide
Generic: chlordiazepoxide hydrochloride and clidinium bromide
Labeler: winder laboratories llcDrug Facts
Product Profile
Brand Name
chlordiazepoxide hydrochloride and clidinium bromide
Generic Name
chlordiazepoxide hydrochloride and clidinium bromide
Labeler
winder laboratories llc
Dosage Form
CAPSULE
Routes
Active Ingredients
chlordiazepoxide hydrochloride 5 mg/1, clidinium bromide 2.5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
75826-134
Product ID
75826-134_3de77685-67e3-815d-e063-6394a90a0fdb
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA212344
DEA Schedule
civ
Listing Expiration
2027-12-31
Marketing Start
2020-12-07
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
75826134
Hyphenated Format
75826-134
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
chlordiazepoxide hydrochloride and clidinium bromide (source: ndc)
Generic Name
chlordiazepoxide hydrochloride and clidinium bromide (source: ndc)
Application Number
ANDA212344 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 5 mg/1
- 2.5 mg/1
Packaging
- 100 CAPSULE in 1 BOTTLE, PLASTIC (75826-134-10)
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3de77685-67e3-815d-e063-6394a90a0fdb", "openfda": {"upc": ["0375826134100"], "unii": ["MFM6K1XWDK", "91ZQW5JF1Z"], "rxcui": ["889614"], "spl_set_id": ["87d1a147-d3c3-4097-aac0-4b19c49eabe3"], "manufacturer_name": ["Winder Laboratories LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE, PLASTIC (75826-134-10)", "package_ndc": "75826-134-10", "marketing_start_date": "20201207"}], "brand_name": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "product_id": "75826-134_3de77685-67e3-815d-e063-6394a90a0fdb", "dosage_form": "CAPSULE", "pharm_class": ["Anticholinergic [EPC]", "Benzodiazepine [EPC]", "Benzodiazepines [CS]", "Cholinergic Antagonists [MoA]", "Decreased Parasympathetic Acetylcholine Activity [PE]", "Digestive/GI System Activity Alteration [PE]", "GI Motility Alteration [PE]"], "product_ndc": "75826-134", "dea_schedule": "CIV", "generic_name": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "labeler_name": "Winder Laboratories LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "active_ingredients": [{"name": "CHLORDIAZEPOXIDE HYDROCHLORIDE", "strength": "5 mg/1"}, {"name": "CLIDINIUM BROMIDE", "strength": "2.5 mg/1"}], "application_number": "ANDA212344", "marketing_category": "ANDA", "marketing_start_date": "20201207", "listing_expiration_date": "20271231"}